Rick Lundberg

Rick Lundberg has nearly 30 years of strategic, operational, and commercial experience in the life sciences industry that ranges from de novo ventures to leading global biopharmaceutical companies. Mr. Lundberg is a member of the company’s founding team and has overall responsibility for corporate development, finance, and administration.

Prior to joining Navitor, Mr. Lundberg founded 7S BioVentures, which provided business development and corporate strategy advisory services to emerging life sciences companies. From 2006 to 2009, he was responsible for ex-U.S. commercial strategy and business development at Targanta Therapeutics. Previously, Mr. Lundberg led therapeutics business development initiatives and managed the genomics services business at Celera Genomics. He began his career at Biogen, where he served for nearly a decade in a broad range of business roles, including business development, program management, investor relations, sales, and marketing.

Mr. Lundberg holds a BA in Biochemical Sciences from Harvard University.